Should we focus on "venous vulnerability" instead of "plaque vulnerability" in symptomatic atherosclerotic patients?
Fabrizio
F
Montecucco
François
F
Mach
D000367:Age Factors; D017130:Angioplasty; D000818:Animals; D050197:Atherosclerosis / Q000453:epidemiology*; D005260:Female; D006801:Humans; D008297:Male; D015912:Thrombolytic Therapy; D054556:Venous Thromboembolism / Q000453:epidemiology*